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ABSTRACT: Colloidal particles with specific binding affinity are
essential for in vivo and in vitro biosensing, targeted drug
delivery, and micrometer-scale self-assembly. Key to these
techniques are surface functionalizations that provide high
affinities to specific target molecules. For stabilization in
physiological environments, current particle coating methods
rely on adsorbed surfactants. However, spontaneous desorption
of these surfactants typically has an undesirable influence on lipid
membranes. To address this issue and create particles for
targeting molecules in lipid membranes, we present here a
surfactant-free coating method that combines high binding
affinity with stability at physiological conditions. After activating
charge-stabilized polystyrene microparticles with EDC/Sulfo-NHS, we first coat the particles with a specific protein and
subsequently covalently attach a dense layer of poly(ethyelene) glycol. This polymer layer provides colloidal stability at
physiological conditions as well as antiadhesive properties, while the protein coating provides the specific affinity to the targeted
molecule. We show that NeutrAvidin-functionalized particles bind specifically to biotinylated membranes and that Concanavalin
A-functionalized particles bind specifically to the glycocortex of Dictyostelium discoideum cells. The affinity of the particles changes
with protein density, which can be tuned during the coating procedure. The generic and surfactant-free coating method reported
here transfers the high affinity and specificity of a protein onto colloidal polystyrene microparticles.
■ INTRODUCTION
Surfaces with a high affinity to specific molecules are crucial in
biological applications such as biosensing1,2 and drug
targeting.3,4 Central to these applications is a particle coating
that provides a high affinity and specificity to certain target
molecules of interest. For example, colloidal particles can be
functionalized with an affinity to particular proteins that are
overexpressed on the cellular membrane of a tumor cell,5 which
enables local drug release at or even in targeted cells. We focus
here on polystyrene microparticles that especially target
molecules embedded in lipid membranes. Such particles are
required in fundamental membrane studies such as membrane
tether pulling,6,7 membrane viscosity measurements,8−10 and
the quantification of membrane-mediated forces.11−14 Fur-
thermore, it has recently been shown that a specific linkage
between particles and lipid membranes can be adopted for the
self-assembly of particles into mobile structures such as
colloidal clusters, strings, and dynamic networks.15−18
A controllable affinity and specificity of colloidal particles
requires a careful design of the surface coating process.1,2,19−22
Next to moieties that provide the actual affinity, hydrophilic
polymers are typically attached to the particle surface, which are
necessary to prevent the undesirable aggregation of particles at
physiological salt concentrations. These seemingly contra-
dicting requirements, specifically attracting moieties next to
generically repelling polymers, are usually met by adsorbing an
amphiphilic polymer onto the colloidal particles before or
during the coating process. These polymers provide steric
stabilization against aggregation while the functional binding
sites of the particles are still accessible. However, amphiphilic
polymers are known to interact with lipid membranes.23−26 If
these colloidal particles are used in lipid membrane studies,
desorbing surfactants may disrupt the lipid membranes and
compromise the accuracy of the corresponding measurements.
Therefore, a surfactant-free coating is required for studies
involving lipid membranes.
To meet this requirement, we have developed a two-step
method yielding stable and specific polystyrene microparticles
that can be applied to lipid membrane studies. First, we created
colloidal particles with a high affinity through immobilization of
proteins that specifically bind to the desired target mole-
cules.27−29 We focus mostly on the use of NeutrAvidin, as its
affinity to biotin is used in many practical applications. This
protocol can readily be used to prepare particles with other
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target specificity, as we demonstrate by also employing the
sugar-binding protein Concanavalin A. Second, we do not
stabilize the colloidal particles by using adsorbed surfactants but
instead by covalent grafting of methoxylpoly(ethylene) glycol
(mPEG) to the particle surface in such a way that it preserves
the affinity and specificity of the tested proteins. At sufficiently
high surface densities, mPEG is known to suppress particle
aggregation.30 Furthermore, a dense mPEG coating has been
proven to suppress nonspecific protein adsorption on the
particles, thus providing “stealth” properties necessary for drug
targeting in living organisms.1,3 These properties make mPEG
an ideal choice as a stabilizer for colloidal particles at
physiological conditions.
In this article, we will first describe the synthesis method and
study the effect of various parameters on the resulting surface
density of avidin. Then, we will assess the binding affinity of
avidin-functionalized colloidal particles on biotinylated giant
unilamellar vesicles (GUVs). Finally, we will show that avidin-
functionalized particles bind specifically to biotinylated lipid
membranes and Concanavalin A-functionalized particles to the
cellular membrane of Dictyostelium discoideum cells.
■ EXPERIMENTAL SECTION
Materials. N-Hydroxysulfosuccinimide sodium salt (98%, Sulfo-
NHS), sodium phosphate (99% Na2HPO4), Pluronic F-127, and
hydrochloric acid (HCl) were acquired from Sigma-Aldrich.
Methoxypoly(ethylene) glycol amine (mPEG, Mw = 5000) was
acquired from Alfa Aesar. Sodium hydroxide (NaOH, 98.5%), sodium
chloride (NaCl, 99%), and sodium azide (NaN3, 99%) were acquired
from Acros Organics. 1-Ethyl-3-(3-dimethylaminopropyl) carbodii-
mide hydrochloride (99%, EDC) was acquired from Carl Roth.
NeutrAvidin (avidin) and biotin-4-fluorescein were acquired from
Molecular Probes. Biotin-5′-TTTAATATTA-3′-Cy3 DNA oligonu-
cleotides (btn-DNA-Cy3) were acquired from Integrated DNA
Technologies. Δ9-Cis 1,2-dioleoyl-sn-glycero-3-phosphocholine
(DOPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[biotinyl-
(polyethylene glycol)2000] (DOPE-PEG-biotin), 1,2-dioleoyl-sn-glyc-
ero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)2000]
(DOPE-PEG), and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-
N-(lissaminerhodamine B sulfonyl) (DOPE-rhodamine) were ac-
quired from Avanti Polar Lipids. Trypsin was acquired from Life
Technologies. All chemicals were used as received. Deionized water
with 18.2 MΩ cm resistivity was used, which was obtained using a
Millipore Filtration System (Milli-Q Gradient A10). PBS consisted of
12.5 mM Na2HPO4, 50 mM NaCl, and 3 mM NaN3 with a pH of 7.5.
Phosphate buffer for cell culture consisted of 2.00 g/L of KH2PO4 and
0.36 g/L of Na2HPO4·H2O with a pH of 6.0. See the Supporting
Infromation for the compositions of the HL5, 3T3, and A549 media.
Particle Preparation. Polystyrene microparticles were prepared
using a surfactant-free dispersion polymerization protocol.31 The
nonfluorescent particles employed in this article were 1.06 ± 0.02 μm
in diameter, and the green fluorescent particles \0.98 ± 0.03 μm. Their
ζ-potentials in water (pH 5.7) were determined to be −54 ± 4 and
−55 ± 4 mV, respectively. These strongly negative values reflect the
high density of carboxylic acid groups (1−10 nm−2) on the particle
surface.31 See the Supporting Information for the synthesis details.
Coating and Stabilization. The particle coating procedure was
extended from a covalent mPEG grafting protocol from the literature30
(see Figure 1). All reactions were performed on a vortex mixer at 4 °C.
The polystyrene particles with carboxylic acid groups were activated by
adding 8 mM EDC and 2.5 mM Sulfo-NHS to the particles, which
were suspended at 20 g/L. The EDC and Sulfo-NHS were dissolved
immediately before use. At this concentration, the hydrochloric acid in
the EDC ensures a pH of 5.3, which was confirmed using a calibrated
Hach PH17-SS ISFET pH probe. After 30 min of mixing, the pH was
brought to 8.6 using 0.2 M NaOH. At this pH, NHS hydrolysis starts,
which we suppressed by performing the reactions at 4 °C. Then,
5−500 μg of protein (NeutrAvidin or Concanavalin A) was added to
750 μL (15 mg) of the activated particles. After a delay time of 2 h, 4.0
mg of mPEG5000-NH2 dissolved in 200 μL of water was added. The
reaction was allowed to proceed for at least 40 h. For the remaining
NHS groups to be removed, the pH was adjusted to 12 for 5 min using
1 M NaOH. For some proteins, this high pH is undesirable, in which
case pH 9 may be used for a longer time period to hydrolyze the NHS
esters at room temperature.32 The particles were washed one time with
10 mM HCl to neutralize the pH and three times with water. Finally,
sodium azide was added to a concentration of 3 mM to prevent
bacterial growth. The colloidal stability of each sample was assessed as
follows: 50 μg of particles was dispersed in 10 μL of 1 M NaCl. After 1
h of mixing, the sample was diluted 20-fold with 1 M NaCl and imaged
using bright field microscopy (Figure 1g). The resulting particle
suspensions can be stored for at least two months at 4 °C. For longer
shelf life, the particle suspensions should be frozen at −20 °C.
Avidin Titration Assay. The number of biotin binding sites on the
particles was measured using a titration assay based on the binding of
biotin-4-fluorescein to the particle-attached avidin. Because of the
strong scattering of the particles, we could not measure the
fluorescence of the avidin-bound biotin-4-fluorescein directly as
described elsewhere.33 Instead, we determined the remaining
fluorescence of the supernatant for different amounts of added
biotin-4-fluorescein. From a single particle batch, precisely known
aliquots of 0.3−0.6 mg of particles were dispersed into 1.00 mL of
PBS. Subsequently, quantities of 0−10 μL of 1.8−7.3 μM biotin-4-
Figure 1. Illustration of the particle coating procedure. (a) Highly carboxylated (COOH) polystyrene particles were first activated using EDC/NHS
so that the carboxylic acid groups form NHS esters. (b) The activated particles were then mixed with a precise quantity of protein at pH 8.6. (c)
After a delay time of typically 2 h, an excess of amine-functionalized methoxypoly(ethelyne) glycol (mPEG-NH2) was added to stabilize the particles.
(d) The resulting particle coating contains the added proteins as well as a dense mPEG layer that provides colloidal stability. (e) A scanning electron
micrograph of the uncoated particles. Light microscopy images after 1 h in 1 M NaCl show that (f) the uncoated polystyrene particles aggregated
strongly and (g) the mPEG-coated particles remained dispersed.
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fluorescein were incubated with the particles for 20 min at 55 °C. After
this, the particles were removed by centrifugation. Then, 750 μL of
supernatant was diluted with 750 μL of PBS, and the fluorescence of
each aliquot was determined using a Varian Cary Eclipse fluorescence
spectrophotometer (ex. 494 nm, em. 524 nm). From the intersection
of the baseline fluorescence and the final slope of the titration curve,
the amount of biotin binding sites in the sample was determined (see
Figure S1). Together with the separately determined dry weight and
diameter of the particles, the amount of biotin binding sites per
particle was computed.
Avidin Fluorescence Assay. To measure the distribution of
biotin binding sites on avidin-functionalized particles within a single
batch, we added a fluorescent marker for use in fluorescence
microscopy. The employed fluorescent marker was a biotin- and
Cy3-functionalized DNA oligonucleotide, as DNA is well soluble in
water and shows no aspecific adsorption to the particle surface. To
stain the particle-attached avidin, we incubated 50 μg of particles with
60 pmol btn-DNA-Cy3 in 310 μL of PBS buffer for 30 min at 55 °C in
a nuclease-free plastic microtube. To be able to use the same protocol
for unstable particles, we added 0.5 wt % of the steric stabilizer
Pluronic F-127 to the PBS buffer (see Materials for the contents).
After cooling to room temperature, the samples were washed three
times with water and one time with PBS. Finally, the samples were
inserted into a rectangular capillary and imaged on a Nikon Ti-E
microscope equipped with a Nikon 100× CFI Apo TIRF oil-
immersion objective (NA = 1.49), Intensilight fluorescent lamp (ex.
540 ± 25 nm, em. 605 ± 55 nm), and a DS-Qi1 monochrome CCD
camera with an exposure time that was set such that all particles had a
fluorescence signal between the camera background and saturation
levels (100−800 ms). In a separate experiment, the background-
corrected emission intensity per feature was confirmed to be
proportional to the exposure time (see Figure S2). The resulting
images were ensured to be in the same focal plane, and the integrated
intensity per particle was computed using Trackpy.34
Sample Preparation. Giant unilamellar vesicles (GUVs) of 10−
100 μm diameter were prepared using the electroformation method.35
The composition was 97.5 wt % DOPC, 0.5 wt % DOPE-rhodamine,
and either 2 wt % DOPE-PEG-biotin or 2 wt % DOPE-PEG. GUV
samples were prepared by consecutive addition of 50 μL of PBS
(diluted to a total osmotic content of 100 mM), 0.5 μL of 3 wt %
particles, and 2 μL of GUVs. Dictyostelium discoideum SadA-GFP Lim-
RFP cells were cultured in HL5 medium. These imaging samples were
prepared by subsequent addition of 50 μL of phosphate buffer, 0.5 μL
of 1.5 wt % particles, and 10 μL of cells.
All samples were prepared on a hydrophobic coverslip that was
incubated for 15 min in a 5% Pluronic F-127 solution and washed
three times with the appropriate buffer. Images were taken 30−45 min
after mixing. See the Supporting Information for additional details on
the GUV preparation, cell culture, and imaging.
■ RESULTS AND DISCUSSION
We describe here a surfactant-free preparation method of
colloidal particles that specifically bind to target molecules. In
this method, polystyrene microparticles are first coated with a
protein that provides the specific affinity and subsequently with
a layer of mPEG that provides stability against aggregation
under physiological conditions (see Figure 1). As protein we
primarily use avidin, which has a high affinity to biotin, and
further show that the method is readily transferable to the
sugar-binding Concanavalin A. In the following, we will
characterize the particle coating and show its affinity and
specificity on vesicles as well as on living cells. First, we study
the colloidal stability of the particles at various physiological
conditions. Second, we quantify how the number of biotin
binding sites on the avidin-coated particles depends on the
synthesis parameters. Then, we measure the binding affinity of
the avidin-coated particles to biotinylated membranes. Finally,
we demonstrate that avidin-coated particles bind specifically to
biotinylated membranes and that Concanavalin A-coated
particles bind specifically to the glycocortex of D. discoideum
cells.
Colloidal Stability. One of the most important require-
ments of a colloidal dispersion is its stability. Without a
polymer coating, colloidal stability relies on Coulomb
repulsion: the surface charge of the particles prevents
aggregation in deionized water. At a physiological salt
concentration, however, the Coulomb force is screened by
counterions so that the short-ranged van der Waals force
induces permanent particle aggregation (see Figure 1e).
Therefore, steric stabilization is necessary to use colloidal
particles at physiological conditions. This involves adsorbing or
grafting a layer of well-soluble polymers to the particle surface.
When particles approach each other, the layers on neighboring
particles will interpenetrate, which costs free energy as the
polymers can occupy less volume.36 For a sufficiently dense and
thick polymer layer, this yields a repulsive force that counteracts
the van der Waals attraction and protects the particles from
aggregating at arbitrary salt concentrations.37
We achieve this steric stabilization here by covalently grafting
methoxypoly(ethylene) glycol (mPEG5000) to the particles by
an NHS/Sulfo-NHS linking procedure.30 mPEG is an excellent
candidate for stabilizing colloidal particles as it is uncharged and
hydrophilic. Furthermore, mPEG coatings have been shown to
reduce the nonspecific adhesion of particles to proteins, cells,
and tissues.20 As these properties make the particles less visible
to the immune system, mPEG coatings are particularly
interesting for drug delivery applications.3
Indeed, we found that after 1 h in 1 M NaCl, the
mPEG5000-coated particles employed here showed excellent
stability against aggregation. We observed that performing the
mPEG coating at 4 °C for a minimum of 24 h is essential for
obtaining the required colloidal stability, which is in agreement
with earlier reports on mPEG-coated particles.30 The ζ-
potential before particle coating (−55 ± 4 mV) clearly
becomes less negative after the mPEG coating (see Table 1),
which provides additional evidence for the presence of a dense
PEG layer.30 The remaining negative charge is caused by
unreacted carboxylic acid groups.
Furthermore, we assessed the stability of the mPEG-coated
particles in a standard PBS buffer and in three typical cell
culture media. After 1 h of mixing, we did not observe any
aggregation of the particles inside any of these solvents. In HL5
medium, the ζ-potential was similar to that in the PBS buffer,
whereas we observed a significant change in both mammalian
cell media (see Table 1). Although HL5 contains mostly salts,
sugars, and amino acids, the A549 and 3T3 cell media contain
significant amounts of proteins from bovine serum. Protein
Table 1. ζ-Potential of mPEG-Coated Particlesa
solvent pH ζ-potential [mV]
water 5.7 −24 ± 4
PBS 7.3 −18 ± 4
HL5 6.6 −15 ± 5
A549 7.6 −7 ± 5
3T3 8.1 −7 ± 5
aMeasurements were taken after 1 h incubation in water, phosphate
buffered saline (PBS), the D. discoideum medium HL5, and
mammalian cell media A549 and 3T3. See Supporting Information
for the precise contents of these media.
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adsorption has been shown to be suppressed but not
completely prevented by a dense mPEG coating such as that
employed here.38,39 Therefore, we attribute the less negative ζ-
potential in the A549 and 3T3 cell media to nonspecific protein
adsorption.
To summarize, the particles described here with a dense layer
of mPEG on their surface do not show aggregation at a high
salt concentration or in several cell culture media. To now
provide these particles with an affinity to a specific molecule, we
introduce an additional step in the procedure: we first coat the
EDC/Sulfo-NHS-activated particles with a functional protein
before saturating the surface with an excess of mPEG (see
Figure 1). The resulting particles possess functional proteins as
well as mPEG polymers on their surface. We still observed that
these particles were stable in 1 M NaCl after 1 h for protein
densities of up to 67 μg/mg of particles. Although the proteins
occupy significant space on the particles (see next section), we
conclude that the density and size of mPEG5000 is still
sufficiently high to protect the particles from aggregating. This
combination of covalent colloidal stability with a specific
binding protein is key to targeting specific molecules on lipid
membranes.
Accessible Binding Sites. In general, a specific binding
affinity of a colloidal particle is provided by a finite number of
binding sites on the particle surface. The number of sites will
directly influence the binding affinity of the particle, and
therefore, we quantified this parameter for the particles
described here. During the coating, we immobilized the protein
via NHS groups on the particles, which are known to form a
covalent amine bond with random lysine residues that are
typically present in the protein exterior.27,28 As an example, we
coated particles with avidin, which is a protein that binds to
biotin with high affinity (∼17 kBT per bond40). Because of this
high affinity and the versatility of avidin, it has been widely
applied as a connector in biochemistry, for instance as a binding
site for attaching biotinylated monocolonal antibodies.41,42 We
use NeutrAvidin here, which is a neutral and nonglycosylated
avidin, and quantify the number of biotin binding sites using a
combined titration and fluorescence assay for several synthesis
conditions.
To rule out noncovalent adsorption of the avidin or mPEG
on the particles during synthesis,43 we performed the protocol
without the EDC/NHS activation (Figure 1a, b). The absence
of NHS esters resulted in particles without biotin binding sites;
at the same time, the particles were unstable in 1 M NaCl. This
proves that the NHS activation is necessary for avidin and
mPEG binding. We conclude that both avidin and mPEG are
covalently linked to particles via amine bonds through the
EDC/NHS chemistry.
The number of biotin binding sites on the particles is
controlled by the amount of avidin that is added during
synthesis. To probe this relation, we changed the quantity of
added avidin between 0 and 7 μg/mg of particles and measured
the resulting average number of biotin binding sites per particle
with a titration assay (Figure 2a). Clearly, the amount of added
avidin allows for continuously changing the average number of
biotin binding sites per particle up to at least 2.9 × 104.
Assuming a protein size of 5 nm, we estimate that at this value
approximately 1% of the particle surface is covered with avidin.
The slope of the linear regression in Figure 2a provides
information on the synthesis yield: the biotin binding capacity
corresponds to 0.71 accessible biotin binding sites per added
avidin protein, which has a total of 4 binding sites. Apart from
the finite chemical yield of the avidin immobilization, we
presume that some of the biotin binding sites are actually
present on the particles but not accessible because of the
random orientations of the avidin proteins,27 steric hindrance
by the covalently grafted mPEG polymers, or unfolding of the
proteins during the pH 12 synthesis step.
Additionally, we measured the distribution of the number of
biotin binding sites per particle using quantitative fluorescence
microscopy. By incubating the particles with btn-DNA-Cy3, we
visualized the accessible biotin binding sites for individual
particles. As can be seen in Figure 2b, the resulting distributions
are broad and skewed toward lower values of fluorescence. The
relatively large spread is a consequence of the random
immobilization of the avidin on the particle surfaces. For this
effect to be mitigated, it is important that the added protein is
well mixed with the particles during the coating procedure.
Here, we achieved this by vortexing the mixture directly after
the addition of protein to the particles.
By combining the distributions from the fluorescence assay
with the quantitative results from the titration assay, we
obtained the most frequently occurring number of biotin
binding sites per avidin-coated particle, which is shown in
Figure 2c together with the one standard deviation spread.
Because of the skewed distributions, the average number of
biotin binding sites (Figure 2a) is higher than the most
frequently occurring number of biotin binding sites (Figure 2c).
Still, this quantity is linear with the amount of added avidin and
therefore can be readily tuned by varying the avidin
concentration.
Figure 2. Amount of biotin binding sites on avidin-coated particles.
(a) The average number of binding sites per particle measured by
titration. Four particle batches with varying amounts of avidin were
analyzed. Error bars denote the measurement precision. (b)
Histograms of the btn-DNA-Cy3 fluorescence of the same particle
batches (see legend) show a skewed distribution for all samples.
Combining the average number of binding sites from the titration
assay (a) with the distributions from the fluorescence microscopy
assay (b), the distribution of binding sites within particles of a single
batch could be recovered, which is displayed in (c). Here, error bars
denote one standard deviation spread of biotin binding sites per
particle in a single batch, and the disks mark the most frequently
occurring value. Lines in (a) and (c) are linear regressions. (d)
Histograms of the btn-DNA-Cy3 fluorescence of five particle batches
with varying delay times between avidin and mPEG addition (see
legend) at a fixed avidin concentration of 3.3 μg/mg. As the
distributions did not change after 0.5 h, we concluded that the avidin
coating was completed within 0.5 h after avidin addition.
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After activating the carboxylic acid particles with NHS, avidin
and mPEG are added sequentially. As the two reactions
compete with one another for the NHS esters, we used a delay
time between avidin and mPEG addition so that the avidin
immobilization is allowed to complete before mPEG starts to
occupy the particle surface area. The duration of this delay may
affect the final avidin density on the particles. To find the
minimum delay time between the addition of avidin and
mPEG, we varied the delay between 0 and 4 h at a fixed amount
of avidin of 3.3 μg/mg of particles. See Figure 2d for the
corresponding distributions of the btn-DNA-Cy3 fluorescence.
As the distributions do not change significantly between 0.5 and
4 h, we conclude that the distribution of linker densities already
reached a steady state within the first 0.5 h. Throughout this
article, we fixed the delay time at 2 h to ensure the complete
grafting of proteins.
To summarize, we have shown that the reported particle
coating method allows for tuning the average number of
accessible biotin binding sites up to 2.9 × 104 per particle,
which is sufficient to achieve high binding affinity and
specificity, as will be demonstrated in the next sections.
Binding Affinity. In the previous section, we have shown
that the avidin-coated particles bind fluorescently labeled biotin
molecules. Next, we investigated whether this binding affinity
also holds for lipid membranes that feature biotin target groups.
As a model membrane, we used giant unilamellar vesicles (10−
50 μm in diameter) that contain biotinylated lipids. After 30
min incubation of these vesicles in a 0.02 vol % particle
suspension, we imaged the vesicles using confocal microscopy.
See Figure 3a for a GUV that was incubated with 3.3 μg/mg of
avidin-coated particles, which clearly adhered to the biotin-
containing membranes.
As the surrounding liquid is stationary, a diffusion-limited
adsorption model seems applicable.44 To explain the depend-
ence of particle adsorption on the avidin density, we presume
that the avidin concentration on the particles determines the
binding probability to biotin-containing membranes. For low
membrane coverage, the covered membrane area fraction is
proportional to the particle concentration in the surrounding
liquid, and therefore, it is reasonable to define a (non-
equilibrium) binding affinity with the membrane area that is
covered by particles ϕA divided by the bulk particle volume
fraction ϕV at a fixed incubation time. We measured this
membrane area fraction ϕA using previously described tracking
methods on the three-dimensional confocal images.13,34,45 The
observed binding affinities (ϕA/ϕV) after 30 min incubation are
shown in Figure 3b. The effect of avidin on the binding affinity
to biotin-containing GUVs is clear: between 0 and 0.3 μg/mg,
the binding affinity increased more than 10-fold from 1.5 ± 0.7
to 18 ± 4. After that, the binding affinity increased for
increasing avidin densities until a membrane area coverage of
1.9% after 30 min in a 0.02 vol % particle suspension was
achieved. At amounts of added avidin larger than 3 μg/mg, we
observed fluctuations in the binding affinities. Next to random
error due to uncertainty in the particle volume fraction, a
possible reason for this is the distribution of the avidin proteins
over the particles (see Figure 2). From this we conclude that
the binding probability of avidin-coated particles increases with
increasing avidin density on the particles.
Binding Specificity. We have shown that, by immobilizing
a protein on the surface of colloidal particles, the affinity to its
target molecule is transferred from the protein to the particle
surface. Now, we investigate whether the binding specificity is
also conserved. For this, we assessed the binding affinity of
three types of functionalized particles to different lipid
membranes. As a control experiment, we first tested the
binding affinity of particles with only mPEG on their surface.
Then, to show the specific targeting to biotinylated surfaces, we
used the avidin-coated particles that we investigated in detail in
the previous sections (3.3 μg avidin per mg particles). Finally,
to show the generality of the coating protocol, we also assessed
particles functionalized with 33 μg/mg of the sugar-binding
protein Concanavalin A (ConA).
The specific binding affinities of these three types of particles
were first tested on model lipid membranes, GUVs, of known
composition (see Experimental Section). In Figure 4a−c, we
show that none of the investigated particles bound to lipid
membranes without exposed biotin molecules: the dense
mPEG coating clearly suppressed aspecific binding to the
GUVs irrespective of the immobilized proteins that are also
present on the particles. On biotinylated membranes, however,
we observed binding of avidin-coated particles with high
affinity, whereas the control and ConA-coated particles did not
show significant binding (Figure 4d−f). Therefore, we conclude
that the coating protocol described here successfully transfers
the specificity of the avidin to colloidal particles.
Additionally, we also investigated the specificity of these
particles to living cells. For D. discoideum cells, we found that
Figure 3. Binding affinity of avidin-coated particles on biotinylated lipid membranes. (a) Three-dimensional confocal image showing a biotinylated
GUV (magenta) that has been incubated for 30 min with avidin-coated particles (green). (b) Membrane area coverage ϕA was measured and
averaged over 10 randomly selected GUVs for varying amounts of avidin on the particles. The particle volume fraction ϕV was 0.021 ± 0.004 vol %.
The vertical error bars denote the uncertainty in binding affinity due to the imprecision in particle volume fraction; the horizontal error bars denote
the uncertainty in the amount of added avidin. The confocal image in (a) corresponds to the point at 3.3 μg/mg of avidin.
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the mPEG coating successfully prohibited adhesion to the cells:
without mPEG coating, 50% of the particles were internalized
by the cells, whereas with mPEG coating, we observed none out
of over 200 observed particles to be stuck or internalized (see
Figure 4g). On the other hand, on two types of mammalian
cells (A549 human lung carcinoma and 3T3 mouse fibroblasts),
we found that the mPEG-coated particles stuck nonspecifically
to the cellular membranes. As these cells are cultured in
protein-rich media, we presume that the observed adhesion was
caused by a protein corona that formed around the particles,
which is supported by the ζ-potential measurements inside
these media (see Table 1). Therefore, we conclude that
protein-rich media may induce aspecific binding of the mPEG-
coated particles.
The particles that were functionalized with avidin also did
not bind to the D. discoideum cells (Figure 4h). These results
are in line with the previous results on GUVs: the presence of
the immobilized protein does not lead to aspecific binding of
the particles. On the other hand, ConA-coated particles did
show significant binding to the cells (Figure 4i). ConA binds
selectively to glucose and mannose residues46 that are present
in the glycocortex of the D. discoideum cells. This ConA
particle-coating is also specific, which we confirmed by the
observation that they did not bind to any of the GUVs (Figure
4c and f). As with the avidin-coated particles to biotinylated
membranes, the binding affinity of the ConA particles to the D.
discoideum cells seems to depend on the amount of ConA on
the particles (see Figure S3). Furthermore, we observed that,
after cleaving glycoproteins from the cellular membranes by the
addition of Trypsin,47 the binding affinity decreased signifi-
cantly.
These observations confirm that the surfactant-free coating
protocol described here readily transfers the specificity of a
certain protein to a colloidal particle. By suppressing non-
specific binding, our method provides a means to design
colloidal particles that “target” specific molecules in lipid
membranes, which has useful applications in fundamental
membrane studies, micrometer-sized self-assembly, and tar-
geted drug release. We demonstrated this target specificity on
GUVs without biotin, GUVs with biotin, and on D. discoideum
cells.
■ SUMMARY AND CONCLUSIONS
To direct colloidal particles to specific molecules in lipid
membranes, we have developed a surfactant-free coating
procedure that produces particles with a high affinity to
specific molecules. A coating with proteins provides the binding
affinity, while at the same time a dense layer of covalently
coupled mPEG gives stability at physiological conditions. As
the method is surfactant-free, the particles are especially useful
for surfactant-sensitive applications, such as studying lipid
membrane properties, also in biological environments.
The protein density on the particles can be tuned to adapt
the binding affinity, which we have shown for the biotin-
binding protein NeutrAvidin using a combined titration and
fluorescence assay. The yield of the coating method is such that
Figure 4. Binding specificity of nonfunctionalized particles, NeutrAvidin-coated particles, and Concanavalin A-coated particles. The specific adhesion
is shown on (a−c) GUVs with only PEG on their surface, (d−f) GUVs with an excess of biotinylated mPEG on their surface, and (g−i) D.
discoideum cells in phosphate buffer. All images are maximum intensity projections of three-dimensional confocal images. For the GUVs in (a−f), the
particles are displayed in green, and the membrane is displayed in magenta. For the cells in (g−i), magenta denotes the filamentous actin, which
visualizes the cell contours. These pictures were chosen such that there were no particles floating in front or behind the cells; otherwise, the cells are
representative of the samples. The scale bars denote 5 μm.
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18% of the biotin binding sites are accessible after the coating
procedure, which is presumably caused by the finite chemical
yield, the random protein orientations, and the high mPEG
coverage that potentially obstructs the binding sites. The largest
observed number of biotin binding sites was 2.9 × 104 per 1.06
μm diameter particle.
These avidin-coated particles spontaneously bind to
biotinylated membranes. We have shown that the amount of
NeutrAvidin on these particles directly influences the binding
affinity. Although particles without avidin did not exhibit any
significant binding to these membranes, avidin-coated particles
reached up to 1.9% membrane coverage after 0.5 h in a 0.02 vol
% particle suspension.
We have shown that the coating procedure can be readily
transferred to the sugar-binding protein Concanavalin A.
Particles functionalized with this protein become specific to
the outside of D. discoideum cells, whereas they do not bind to
biotinylated membranes. On the other hand, although the
avidin-coated particles bind to biotinylated GUVs, they do not
bind to these cells. This shows that the specificity of a protein
can be transferred successfully to the surface of the colloidal
particles.
Our surfactant-free coating method makes colloidal poly-
styrene particles selectively adhesive to certain targeted
molecules at physiological conditions. The fact that the coating
procedure only applies covalently linked mPEG as stabilizer
makes it applicable to cases in which surfactants are
undesirable. Provided that they remain in their functional
state throughout the process, the procedure is readily adjustable
to include different proteins. This will provide custom colloidal
particles for use in future lipid membrane measurements,
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(7) Koster, G.; Cacciuto, A.; Dereńyi, I.; Frenkel, D.; Dogterom, M.
Force barriers for membrane tube formation. Phys. Rev. Lett. 2005, 94,
068101.
(8) Dimova, R.; Dietrich, C.; Hadjiisky, A.; Danov, K.; Pouligny, B.
Falling ball viscosimetry of giant vesicle membranes: Finite-size effects.
Eur. Phys. J. B 1999, 12, 589−598.
(9) Hormel, T. T.; Kurihara, S. Q.; Brennan, M. K.; Wozniak, M. C.;
Parthasarathy, R. Measuring lipid membrane viscosity using rotational
and translational probe diffusion. Phys. Rev. Lett. 2014, 112, 188101.
(10) van der Wel, C.; Heinrich, D.; Kraft, D. J. Microparticle
assembly pathways on lipid membranes. Biophys. J. 2017, 113, 1037−
1046.
(11) Koltover, I.; Rad̈ler, J. O.; Safinya, C. R. Membrane mediated
attraction and ordered aggregation of colloidal particles bound to giant
phospholipid vesicles. Phys. Rev. Lett. 1999, 82, 1991−1994.
(12) Sarfati, R.; Dufresne, E. R. Long-range attraction of particles
adhered to lipid vesicles. Phys. Rev. E 2016, 94, 012604.
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